CPS1 and gastric adenocarcinoma: In the study of gastric carcinogenesis by Fang et al., the immunoreactivity of CPS1 protein reveals gradually lower expression from intestinal metaplasia, low-grade dysplasia and high-grade dysplasia to intestinal-type gastric adenocarcinoma [16].